ARCHIVES

No Benefit For Cetuximab In Early-Stage Colon Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007